A protein relational database and protein family knowledge bases to facilitate structure-based design analyses

Chemical Biology and Drug Design

Volumn 76, Issue 2, 2010, Pages 142-153

  Mobilio, Dominick ^a   Walker, Gary ^a   Brooijmans, Natasja ^a   Nilakantan, Ramaswamy ^a   Denny, R Aldrin ^b   Dejoannis, Jason ^c   Feyfant, Eric ^b   Kowticwar, Rupesh K ^d   Mankala, Jyoti ^d   Palli, Satish ^d   Punyamantula, Sairam ^d   Tatipally, Maneesh ^d   John, Reji K ^d   Humblet, Christine ^b  

^a WYETH RESEARCH   (United States)

^b PFIZER INC   (United States)

^c ACCELRYS INC   (United States)

^d GVK BIOSCIENCES PVT LTD   (India)

Author keywords

Crystallography; Database; Protein structure; Protein ligand interactions; Structure based drug design; X ray

Indexed keywords

LIGAND; PROTEIN; MATRIX METALLOPROTEINASE; PROTEIN KINASE;

ARTICLE; ATOM; CHEMICAL STRUCTURE; ENZYME ACTIVE SITE; GEOMETRY; INFORMATION RETRIEVAL; KINASE KNOWLEDGE BASE; MATRIX METALLOPROTEINASE KNOWLEDGE BASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATA BANK; PROTEIN DATABASE; PROTEIN INTERACTION; PROTEIN RELATIONAL DATABASE; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; CHEMISTRY; DRUG DESIGN; KNOWLEDGE BASE;

PYRONIA TITHONUS;

DATABASES, PROTEIN; DRUG DESIGN; KNOWLEDGE BASES; MATRIX METALLOPROTEINASES; PROTEIN KINASES;

EID: 77954357255     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2010.00994.x     Document Type: Article

References (25)

1. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. (2000) The Protein Data Bank. Nucleic Acids Res 28 : 235 242.
2. Aung Z., Tan K.-L. (2007) Rapid retrievalof protein structures from databases. Drug Discov Today 12 : 732 739.
3. Szabadka Z., Grolmusz V. (2006) Building a Structured PDB: The RS-PDB Database, Proceedings of the 28th IEEE EMBS Annual International Conference
4. Szabadka Z., Grolmusz V. (2007) High throughput processing of the structural information in the protein data bank. J Mol Graph Model 25 : 831 836.
5. Bourne P.E., Berman H.M., McMahon B., Watenpaugh K.D., Westbrook J.D., Fitzgerald P.M.D. (1997) Macromolecular crystallographic information file. Methods Enzymol 277 : 571 590.
6. Westbrook J.D., Bourne P.E. (2000) STAR/mmCIF: an ontology for macromolecular structure. Bioinformatics 16 : 159 168.
7. Gunther J., Bergner A., Hendlich M., Klebe G. (2003) Utilising Structural Knowledge in Drug Design Strategies: applications Using Relibase. J Mol Biol 326 : 621 636.
8. Hendlich M., Bergner A., Gunther J., Klebe G. (2003) Relibase: design and Development of a Database for Comprehensive Analysis of Protein-Ligand Interactions. J Mol Biol 326 : 607 620.
9. Schreyer A., Blundell T. (2009) CREDO: a protein-ligand interaction database for drug discovery. Chem Biol Drug Des 73 : 157 167.
10. Bikker J.A., Brooijmans N., Wissner A., Mansour T.S. (2009) Kinase domain mutations in cancer: implications for small molecule drug design strategies. J Med Chem 52 : 1493 1509.
11. Huse M., Kuriyan J. (2002) The conformational plasticity of protein kinases. Cell 109 : 275 282.
12. Liu Y., Gray N.S. (2006) Rational design of inhibitors that bind to inactive kinase conformations. Nat Chem Biol 2 : 358 364.
13. Akella R., Moon T.M., Goldsmith E.J. (2008) Unique MAP Kinase binding sites. Biochim Biophys Acta 1784 : 48 55.
14. Burke J.R., Pattoli M.A., Gregor K.R., Brassil P.J., MacMaster J.F., McIntyre K.W. et al. (2003) BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem 278 : 1450 1456.
15. Ohren J.F., Chen H., Pavlovsky A., Whitehead C., Zhang E., Kuffa P. et al. (2004) Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.[erratum appears in Nat Struct Mol Biol. 2005 Mar;12(3):278]. Nat Struct Mol Biol 11 : 1192 1197.
16. Pargellis C., Tong L., Churchill L., Cirillo P.F., Gilmore T., Graham A.G. et al. (2002) Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat Struct Biol 9 : 268 272.
17. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. (2002) The Protein Kinase Complement of the Human Genome. Science 298 : 1912 1934.
18. Eddy S.R. (1995) Multiple alignment using hidden Markov models. Proc Int Conf Intell Syst Mol Biol 3 : 114 120.
19. Zhang J., Yang P.L., Gray N.S. (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9 : 28 39.
20. Brooijmans N., Chang Y.-W., Mobilio D., Denny R.A., Humblet C. (2010) An Enriched Structural Kinase Database to Enable Kinome-Wide Structure-Based Analyses and Drug Discovery. Protein Sci 19 : 763 774.
21. Aureli L., Gioia M., Cerbara I., Monaco S., Fasciglione G.F., Marini S. et al. (2008) Structural bases for substrate and inhibitor recognition by matrix metalloproteinases. Curr Med Chem 15 : 2192 2222.
22. Overall C.M., Kleifeld O. (2006) Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6 : 227 239.
23. Pirard B. (2007) Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov Today 12 : 640 646.
24. Rush T.S. III., Powers R. (2004) The application of X-ray, NMR, and molecular modeling in the design of MMP inhibitors. Curr Top Med Chem 4 : 1311 1327.
25. Brooijmans N., Mobilio D., Walker G., Denny R.A., Feyfant E., Diller D. et al. (2009) A structural informatics approach to mine kinase knowledge bases. Drug Discov Today 15 : 203 209.